The Blood Warmer Devices Market reached a valuation of US$ 236.90 million in 2024 and is forecast to grow at a CAGR of 8.80% from 2025 to 2032. This rapid expansion reflects the increasing adoption of temperature-regulated fluid delivery systems across emergency rooms, operating theaters, and intensive care units.
Blood warmer devices are essential tools in modern medical settings. They are designed to heat blood, plasma, or intravenous (IV) fluids to a temperature compatible with the human body, typically around 37°C. This is critical to prevent hypothermia, a condition that can lead to cardiac arrhythmias, impaired coagulation, and increased morbidity, particularly in trauma patients and surgical environments.
The market is driven by the growing need to improve patient outcomes, reduce perioperative complications, and meet strict clinical guidelines. From battlefield medicine to neonatal intensive care, blood warmers serve as a critical line of defense in maintaining thermal stability during transfusions or large fluid administration.